Nuclear medicine physicians should take not only a patient’s history, but also his or her “future.” Patients who travel after a diagnostic or therapeutic nuclear medicine procedure can accidentally trip alarms designed to catch terrorists smuggling radioactive material.
Nuclear medicine physicians should take not only a patient's history, but also his or her "future." Patients who travel after a diagnostic or therapeutic nuclear medicine procedure can accidentally trip alarms designed to catch terrorists smuggling radioactive material.
Patients can trigger radiation detectors up to three months after the administration of some nuclear therapies, according to a study presented at the 2004 RSNA meeting.
Dr. Lionel Zuckier and colleagues at the New Jersey University School of Medicine and Dentistry assessed the potential duration of radionuclides in the body by analyzing their sensitivity to detectors used by the Department of Homeland Security.
Using five different portable detectors, the researchers tested seven substances: thallium-201, technetium-99m, gallium-67, iodine-123, iodine-131, indium-111, and F-18 FDG.
They found that I-131 (including Bexxar, the non-Hodgkin's lymphoma treatment) may trigger an alarm up to 95 days postadministration. Detectable traces of the other radionuclides remain in the system for varying lengths of time:
All five detectors in the experiment exhibited similar sensitivity.
While this is not a new problem (in 1986 two nuclear medicine patients set off detectors in the White House), it may become a more commonplace occurrence as portable radiation monitors proliferate and the number of nuclear medicine scans increases, said Zuckier, a professor of radiology at the New Jersey university.
The number of portable devices in use in the U.S. could be as high as 10,000, according to DHS figures. The number of diagnostic and therapeutic nuclear medicine procedures in 2002 was close to 20 million and increasing nearly 10% annually, according to figures from the Society of Nuclear Medicine.
One man a few years ago set off an alarm in a tunnel while on a bus ride from New York to Atlantic City. He had ignored warnings from his physician regarding travel restrictions.
The SNM recommends that physicians give patients a letter detailing the procedure and its date, the radionuclide and its half-life, and 24-hour contact information.
For more information from the Diagnostic Imaging archives:
Federal agency adds x-rays to carcinogen warning list
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.
FDA Clears Remote Scanning Support Platform for MRI, CT and PET/CT
March 25th 2024The multimodality system nCommand Lite reportedly facilitates real-time remote imaging guidance on scanning parameters and procedure assessments to licensed technologists for a variety of imaging modalities including CT and MRI.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.